Colinz Laboratories Limited (BOM:531210)
51.74
-2.72 (-4.99%)
At close: Feb 12, 2026
Colinz Laboratories Revenue
Colinz Laboratories had revenue of 14.34M INR in the quarter ending December 31, 2025, a decrease of -2.21%. This brings the company's revenue in the last twelve months to 58.40M, down -12.92% year-over-year. In the fiscal year ending March 31, 2025, Colinz Laboratories had annual revenue of 65.28M, down -7.14%.
Revenue (ttm)
58.40M
Revenue Growth
-12.92%
P/S Ratio
2.17
Revenue / Employee
898.40K
Employees
65
Market Cap
126.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 65.28M | -5.02M | -7.14% |
| Mar 31, 2024 | 70.30M | -1.25M | -1.75% |
| Mar 31, 2023 | 71.55M | 1.81M | 2.59% |
| Mar 31, 2022 | 69.74M | 8.15M | 13.24% |
| Mar 31, 2021 | 61.59M | -14.44M | -19.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Unjha Formulations | 148.12M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Emmessar Biotech & Nutrition | 20.59M |